Corvus Pharmaceuticals Inc. (CRVS)

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value (x$1000) Activity % Port
1.
OrbiMed Advisors

Samuel Isaly

8,053,298 $24,804 +19% 0.23%
2. 3,275,616 $10,089 1.61%
3. 3,229,426 $9,947 +67% 0.37%
4. 663,470 $2,043 -17% 0%
5.
Stonepine Capital

Timothy P. Lynch

316,279 $974 0.52%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$2.80 35,714 Officer, Director 35,714 2021-05-04 Filing
$3.50 1,285,714 Large Shareholder, Director 8,053,298 2021-02-17 Filing
$3.50 1,285,714 Large Shareholder, Director 8,053,298 2021-02-17 Filing
$3.50 100,000 Officer, Director 1,278,515 2021-02-17 Filing
$3.00 14,736 Officer, Director 1,178,515 2019-11-13 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$5.37 741,440 Large Shareholder 1,389,498 2020-07-08 Filing
$5.25 796,622 Large Shareholder 2,130,938 2020-07-07 Filing
$4.00 1,400,000 Large Shareholder 2,927,560 2019-07-25 Filing
$5.01 53,240 Large Shareholder 4,327,560 2019-07-24 Filing
$5.32 39,716 Large Shareholder 4,380,800 2019-07-23 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value (x$1000) % Port
1. 1,000,119 $3,081 0%
2. 679,132 $2,092 0.41%
3. 416,649 $1,283 0%
4. 348,756 $1,074 0%
5. 336,748 $1,037 0%
News See All